Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer.
D000236:Adenoma / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002291:Carcinoma, Papillary / Q000188:drug therapy; D003470:Culture Media; D046508:Culture Techniques; D004717:Endometrium; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis / Q000517:prevention & control; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D014228:Triaziquone / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D003470:Culture Media; D014228:Triaziquone